tiprankstipranks
Trending News
More News >
Kringle Pharma, Inc. (JP:4884)
:4884
Japanese Market

Kringle Pharma, Inc. (4884) Financial Statements

Compare
0 Followers

Kringle Pharma, Inc. Financial Overview

Kringle Pharma, Inc.'s market cap is currently ¥2.96B. The company's EPS TTM is ¥-25.57; its P/E ratio is -3.04; Kringle Pharma, Inc. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 72.22M¥ 80.04M¥ 69.25M¥ 391.83M¥ 289.76M
Gross Profit¥ 0.00¥ 80.04M¥ 69.25M¥ 303.42M¥ 218.16M
Operating Income¥ -909.45M¥ -817.88M¥ -888.76M¥ -426.17M¥ -357.88M
EBITDA¥ -914.76M¥ -817.88M¥ -888.76M¥ -426.17M¥ -357.88M
Net Income¥ -916.25M¥ -756.45M¥ -854.15M¥ -331.83M¥ -301.17M
Balance Sheet
Cash & Short-Term Investments¥ 1.62B¥ 2.31B¥ 2.14B¥ 2.76B¥ 2.14B
Total Assets¥ 2.08B¥ 2.76B¥ 2.62B¥ 3.21B¥ 2.64B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -1.62B¥ -2.31B¥ -2.14B¥ -2.76B¥ -2.14B
Total Liabilities¥ 770.11M¥ 648.92M¥ 596.95M¥ 419.50M¥ 129.48M
Stockholders' Equity¥ 1.31B¥ 2.11B¥ 2.02B¥ 2.79B¥ 2.51B
Cash Flow
Free Cash Flow¥ 0.00¥ -661.17M¥ -689.10M¥ 15.80M¥ -560.92M
Operating Cash Flow¥ -755.78M¥ -661.17M¥ -689.10M¥ 15.80M¥ -560.92M
Investing Cash Flow¥ -154.01M¥ -121.36M¥ -120.88M¥ -254.38M¥ 0.00
Financing Cash Flow¥ 84.14M¥ 838.23M¥ 69.16M¥ 603.11M¥ 595.90M
Currency in JPY

Kringle Pharma, Inc. Earnings and Revenue History

Kringle Pharma, Inc. Debt to Assets

Kringle Pharma, Inc. Cash Flow

Kringle Pharma, Inc. Forecast EPS vs Actual EPS